Clinical Trials at Marea

As of August 2026, 1 paid clinical trial is recruiting at Marea in Memphis, Tennessee. Active studies at this site cover conditions such as Sickle Cell Disease, Acute Myeloid Leukemia and Neuroblastoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 10, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1 clinical trial at Marea

·Clear filters·

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

for Hypertriglyceridemia

Sites in Memphis +25 more locations

Sponsor: Marea Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07028749·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

Common conditions studied in Memphis

Sickle Cell Disease (19 active studies)
Cancer (11 active studies)
Acute Myeloid Leukemia (9 active studies)
Neuroblastoma (8 active studies)
Acute Lymphoblastic Leukemia (7 active studies)
Malignant Solid Neoplasm (7 active studies)

Leading research sponsors in Memphis

St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Children's Oncology Group
SWOG Cancer Research Network
University of Tennessee

Frequently asked questions

How many paid clinical trials are currently recruiting in Memphis?

There are approximately 468 recruiting clinical trials in Memphis, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Memphis pay participants?

Most recruiting trials in Memphis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Memphis?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Memphis?

The most common conditions under active study in Memphis include Sickle Cell Disease (19), Cancer (11), Acute Myeloid Leukemia (9), Neuroblastoma (8), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Memphis?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Memphis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Memphis?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Memphis?

Recruiting research sites in Memphis include St. Jude Children's Research Hospital, Baptist Memorial Hospital and Cancer Center-Memphis, Saint Jude Children's Research Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Memphis right now?

The largest active categories in Memphis are Cancer & tumors (174), Cardiovascular (25), Neurology & pain (23). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Related healthcare resources in Tennessee

Latest Tennessee clinical trials research report

Trials by condition in Memphis

Sickle Cell Disease· 19 Acute Myeloid Leukemia· 9 Neuroblastoma· 8 Hodgkin Lymphoma· 6